CG
AXNX

Cutler Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Cutler Group’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-800
Closed -$8K – 5647
2020
Q3 		$8K Sell
800
-2,900
-78% -$121K ﹤0.01% 3197
2020
Q2 		$2K Sell
3,700
-900
-20% -$31K ﹤0.01% 3879
2020
Q1 		$2K Buy
+4,600
New +$137K ﹤0.01% 3587

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Cutler Group's AXNX Position: Q1 2021 in Review

Cutler Group sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2021, closing a stake of 281 shares — an estimated $14K sold.

Cutler Group first reported a position in AXNX in Q3 2020 and held it in 2 quarters. The position peaked at $55K in Q3 2020. 160 funds tracked by Wall St. Rank hold AXNX as of Q1 2021.

  • Cutler Group reported no remaining Axonics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 281 Axonics, Inc. Common Stock shares in Q1 2021, an estimated $14K.
  • Cutler Group first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Cutler Group's Axonics, Inc. Common Stock position peaked at $55K in Q3 2020.
  • 160 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.